NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,286,952 | -24.4% | 1,211,600 | +0.0% | 0.62% | -14.9% |
Q2 2023 | $30,793,788 | -21.0% | 1,211,400 | +12.4% | 0.73% | -21.2% |
Q1 2023 | $38,966,085 | -8.7% | 1,077,900 | 0.0% | 0.93% | -9.4% |
Q4 2022 | $42,684,840 | +16.4% | 1,077,900 | +37.0% | 1.03% | +8.4% |
Q3 2022 | $36,674,000 | +8.2% | 787,000 | +1.8% | 0.95% | -4.0% |
Q2 2022 | $33,894,000 | -35.1% | 773,300 | +7.2% | 0.99% | -25.0% |
Q1 2022 | $52,186,000 | -9.8% | 721,500 | +1.1% | 1.31% | -1.7% |
Q4 2021 | $57,884,000 | -21.8% | 714,000 | +12.3% | 1.34% | -14.1% |
Q3 2021 | $73,983,000 | -16.0% | 635,700 | +19.7% | 1.56% | -10.6% |
Q2 2021 | $88,034,000 | +30.1% | 531,000 | +9.5% | 1.74% | +17.9% |
Q1 2021 | $67,658,000 | -1.0% | 485,000 | +22.8% | 1.48% | +1.8% |
Q4 2020 | $68,375,000 | +27.2% | 395,000 | +2.3% | 1.45% | +6.3% |
Q3 2020 | $53,770,000 | +16.6% | 386,000 | 0.0% | 1.36% | +7.8% |
Q2 2020 | $46,115,000 | +33.3% | 386,000 | +11.6% | 1.26% | -11.5% |
Q1 2020 | $34,593,000 | +5.5% | 346,000 | +24.0% | 1.43% | +38.0% |
Q4 2019 | $32,794,000 | +57.3% | 279,000 | +15.1% | 1.04% | +24.7% |
Q3 2019 | $20,848,000 | +64.5% | 242,500 | +24.0% | 0.83% | +81.0% |
Q2 2019 | $12,674,000 | +484.3% | 195,500 | +463.4% | 0.46% | +446.4% |
Q1 2019 | $2,169,000 | – | 34,700 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |